RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

"We are very excited to transition this fully-integrated API Pharmaceutical site, with its substantial reaction capacity, site infrastructure and attractive location, we are confident in the potential ...

−CDMO with a Six Decades-Long Reputation for Quality and Service Doubles Its Capacity to Take on New Development Projects− MORTON GROVE, Ill.--(BUSINESS WIRE)--Regis Technologies, Inc. today announced ...

TOKYO, October 22, 2015 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today the decision to construct a new plant for manufacturing antibody active pharmaceutical ingredients (API) ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors” - The Business Research Company LONDON, GREATER LONDON, UNITED ...

A CDMO championing a commitment to patients may sound like lip service or branding, but truly patient-centric CDMOs offer ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

Poor API quality may often lead to delays in production and a shortage of supply. The API is, one might say, the most important element in a pharmaceutical product. Poor-quality APIs that do not meet ...

Raman Spectroscopy is an optical spectroscopy technique that provides a molecular fingerprint of a sample. Used as a practical analysis technique used inside and outside of the laboratory, Raman ...